Search Results 911-920 of 16939 for Radioisotope
This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...
ROCHESTER, Minn. — Mayo Clinic Comprehensive Cancer Center researchers will present their latest radiation oncology findings at the 2025 American Society for ...
This type of cancer starts in the small intestine. Find out more about symptoms and treatments, including surgery, chemotherapy and targeted therapy.
MT-125 is a type of study treatment which acts on cancer cells in the brain to destroy them. It will be administered on the same day as your standard of care ...
Researchers will use abnormal blood and/or bone marrow cells, or materials derived from these abnormal cells, like DNA, RNA, protein or plasma, in laboratory ...
The primary purpose of this study is to evaluate the safety, tolerability of single-ascending doses of BIIB100 in adults with amyotrophic lateral sclerosis (ALS) ...
About this study. The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of ...
The purpose of this study is to offer the best management possible for patients with brain arteriovenous malformations (AVMs) (ruptured or unruptured) in ...
Mayo Clinic doctors and scientists are active in the latest research on bone cancers, including osteosarcoma. Cancer research is conducted in coordination with ...
The purpose of this study is to look at safety and patient comfort during eye injections. Specifically, it will look to see if an experience is improved with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!